| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Training > Training |
|
Useful Advices - Training
This article is set to determine who should pay
for the training of the labour force. Should the individual, the employer, or perhaps the government, (through various schemes) fund the future training of According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product employees in the
United Kingdom? Looking at who will be most benefited from this training and wages we may be able to conclude whether it is the employer, the employee or the government who will benefit ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ost. If we look at the concept of training then we see that it is an investment to train employees up so that they are able to produce more as they will have more knowledge and skills to do that job. Dif lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. erent production is due to difference in training of otherwise
homogenous workers. Human capital emphasises the importance of education and training in employment. This can be split into two types of tra here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ining, this first being general
training which would be useful within the firm but also outside of it
too, this is training such as education received at schools, colleges
and universities. The second typ d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro of training is Job specific training
which would seem to be useful only within the firm that is doing the
training as the skills may only be applied to that job, and no other. Enterprisetraining is more ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc losely tailored to the specific needs of
enterprises than is initial education. It is provided in response to immediate occupational skill shortages resulting from technological and organisational restru easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi cturing… An important motivation for individuals to invest in training would be that the new skills raise productivity linking them to higher earnings potential. There are two main alternative theories t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically the Human Capital model
these are Screening and signalling, also the agency theory. If we look at the screening and signalling theory then for example employers are looking for the better educated worker and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ and are willing
to pay a higher price for added skills. In his signalling model Spence suggests that firms faced with hiring decision may pay more for better educated workers even if education has no ef ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ect on productivity. Could it
be more value efficient for the firms to train the workers themselves? Potential employees will acquire high levels of education to signal their ability to employers and at t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a he same time these employers are
using education as a screen, to increase the hiring of productive
workers by only hiring potential employees that have high levels of
education. The agency theory suggest dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod to us that the employer is seeking to
benefit or punish the employee in accordance their performance
possibly production wise. This theory basically means that the training and education have less effec cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin upon the wage determination than the human capital theory and
the signalling and screening theory would suggest. This theory
suggests that the more productive workers are, the more benefit (in
wages) the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen firm is likely to give them and for those workers that do
not produce as well, or slack the firm may punish by either making
them unemployed or not giving bonuses. It is focused upon giving the firm givi t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel g the employees incentives to
perform better, whether this can apply to jobs that require a lot of
training such as operating complicated programs on a computer, in this
case without the training no matte ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust how good the incentive is the job
cannot be completed without the relevant training. In this case then
employees may try to already achieve the skills required by the job. The agency theory suggests that y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products wages are paid below the Marginal
Revenue product of labour, and the Performance related pay is
introduced to the firm this is to ensure that W
MRPL. For an individual there is a need to weigh up the co . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ts and benefits
of investing into training, these are the split into the direct costs
such as tuition fees, books required, etc, and also consider the
indirect costs such as the wages foregone in the actu elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip l time of
training. Would the benefit received in the future be able to compare
the benefits that would be foregone in the time of training?
distinctively explained by the opportunity cost of the training tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Your EQ Skills Will Land You The Job Everytime
|